- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01148563
Louisiana State University Health Care Sciences Division (LSU HSCD) Tele-Health Projects: Adult CHF Patient Population (TeleHealth:CHF)
January 23, 2024 updated by: Pennington Biomedical Research Center
LSU HCSD Tele-Health Projects: Adult Systolic Heart Failure Patient Population
The purpose of this research study is to see whether a tele-health intervention can improve health, functioning status, emotional status, quality of life, and patient satisfaction for patients with Congestive Heart Failure (CHF) and to examine the cost benefits of this intervention.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
136
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70805
- Earl K. Long Medical Center
-
Houma, Louisiana, United States, 70363
- Leonard J. Chabert Medical Center
-
Lafayette, Louisiana, United States, 70506
- University Medical Center
-
Lake Charles, Louisiana, United States, 70607
- WO Moss Regional Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- equal to or greater than 18 years old
- 1 + past CHF diagnosis in LSU database, with history of CHF diagnosis extending back for 12 months
- LSU primary care or chronic disease clinic patient for equal or greater than 6 months.
- On CHF medication for equal to or greater than 6 months
- Have had a past echocardiogram
- Mental competency to consent and participate (determined by clinical judgment and chart abstraction)
- Physically able to use in-home equipment (or presence of a household member who can assist the subject in equipment use)
- Currently-working conventional telephone line at primary residence
- Grounded electrical power supply at primary residence
- Anticipation of remaining in the LSU HCSD patient population for the next year
- Not on home oxygen therapy
- No planned surgery within the next six months
- Living at home (not institutionalized)
- No history of major organ transplant
- No diagnosis of metastatic or inoperable cancer
- Not under treatment for cancer
- Not under treatment for end-stage renal disease or end-stage liver disease
- 1 + emergency department visit or inpatient stay in past 12 months
Exclusion Criteria:
- Are on home oxygen
- Have a planned surgery within the next 6 months
- Have a history of major organ transplant
- Have a diagnosis of metastatic or inoperable cancer
- Are under treatment for cancer
- Are under treatment for end-stage renal disease or end-stage liver disease
- Have HIV/AIDS
- Have a cognitive condition, such as Alzheimer's or dementia that would make it difficult for you to understand how to use the tele-health device.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Standard Care
The Standard Care group will continue regular LSU HCSD disease management care for heart failure patients with no additional intervention.
|
|
Active Comparator: Tele-health Monitoring Group
The tele-monitoring intervention group will have the continual standard care from their physician plus the tele-health monitoring.
The tele-health monitor will collect the following data: weight, blood pressure, pulse oximetry, pulse rate, & patient responses to disease-specific questions regarding changes in state of health for 6 months.
|
Daily tele-health monitoring data will be collected from randomized participants.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Events Per Person-year
Time Frame: 12 months
|
(Number of emergency department visits + number of inpatient stays) / person-year
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
U.S. Dollars Per Person-year
Time Frame: 12 months
|
(emergency department costs + inpatient costs) / person-year
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Lee Arcement, MD, Louisiana State University Health Care Services Division
- Study Chair: Michael Kaiser, MD, Louisiana State University Health Care Services Division
- Study Chair: Ronald Horswell, PhD, Louisiana State University Health Care Services Division
- Study Chair: Jay Besse, BS, Louisiana State University Health Care Services Divison
- Study Chair: Timothy S. Church, MD, MPH, PhD, Pennington Biomedical Research Center
- Study Chair: Valerie H. Myers, PhD, Pennington Biomedical Research Center
- Study Chair: Donna H. Ryan, MD, Pennington Biomedical Research Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2009
Primary Completion (Actual)
December 1, 2010
Study Completion (Actual)
April 1, 2011
Study Registration Dates
First Submitted
June 18, 2010
First Submitted That Met QC Criteria
June 18, 2010
First Posted (Estimated)
June 22, 2010
Study Record Updates
Last Update Posted (Estimated)
January 25, 2024
Last Update Submitted That Met QC Criteria
January 23, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PBRC 29003
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Congestive Heart Failure
-
Echosense Ltd.WithdrawnCongestive Heart Failure (CHF)United States
-
Corthera, Inc.(formerly BAS Medical, Inc.), a member...TerminatedCongestive Heart Failure (CHF)Russian Federation
-
Meir Medical CenterUnknown
-
Nihon KohdenTerminatedHeart Failure,CongestiveUnited States
-
Adnan Kastrati, MDBiotronik SE & Co. KGCompleted
-
Signature Medical, Inc.WithdrawnHeart Failure,Congestive
-
Abbott Medical DevicesCompletedCongestive Heart Failure TreatedItaly
-
Echosense Ltd.Terminated
-
ELA Medical, Inc.Approved for marketing
-
Magenta Medical Ltd.TerminatedCongestive Heart Failure | Heart Failure, Congestive | Acute Heart FailureCroatia, Belgium, Serbia
Clinical Trials on Tele-health Monitoring
-
Mayo ClinicPreventiceCompleted
-
CAMC Health SystemWVCTSICompletedPeripheral Vascular Disease
-
Pennington Biomedical Research CenterLouisiana State University Health Care Services DivisionCompletedHypertension | Obesity | Diabetes | OverweightUnited States
-
Yuksek Ihtisas UniversityCompletedCOVID-19 PandemicTurkey
-
University of Southern CaliforniaCompletedHypoglycemia | Diabetes Mellitus, Type 1United States
-
University of AarhusCompletedChronic Obstructive Pulmonary Disease, COPDDenmark
-
University Hospital, Strasbourg, FranceNot yet recruitingCare After Going to Intensive CareFrance
-
T.C. ORDU ÜNİVERSİTESİCompleted
-
Ain Shams UniversityNot yet recruiting
-
Shalvata Mental Health CenterSHL Telemedicine Ltd.UnknownSchizophrenia | Schizoaffective DisorderIsrael